Advertisement
Videos
Advertisement

Clinical Trials and Cancer: The Lessons, Paradoxes and Positives

Wed, 09/29/2010 - 10:29am

Investor, Andy Smith, reviews some of the lessons from cancer clinical trials and examples of what investors have learned from compounds in development and a paradox in oncology clinical trials. Companies mentioned in this talk include AstraZeneca, OSI Pharma and Antisoma.

You need to upgrade your Flash Player!

This web site makes use of the Macromedia Flash player 8.

VIDEO PLAYER by 3b nexus
Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading